Skip To Main Content
Nankoku Japan on Muck Rack

Nankoku Japan

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nankoku

Contact Nankoku, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Skin ulcer at the injection site of BNT162b2 mRNA COVID‐19 vaccine

|
By Natsuko Aoki, Nankoku Japan, Yusuke Saruta, Sae Tanaka
| ncbi.nlm.nih.gov
Since February 2021, coronavirus disease 2019 (COVID‐19) vaccines have been administrated to elderly persons aged over 65 years as a priority in Japan and reached nearly 100 million doses in 6 months. Meanwhile, a variety of adverse events have been reported including skin diseases such as a delayed hypersensitivity reaction at the injection site (so called “COVID arm”) as well as more systemic symptoms such as urticaria and disseminated erythematous rash.
Open in Who Shared Issue with article?
See all 1 articles